title: Phase variation of PorA, a major outer membrane protein, mediates escape of bactericidal antibodies by Neisseria meningitidis.
abstract: Several outer membrane proteins of Neisseria meningitidis are subject to phase variation due to alterations in simple sequence repeat tracts. The PorA protein is a major outer membrane protein and a target for protective host immune responses. Phase variation of PorA is mediated by a poly-G repeat tract present within the promoter, leading to alterations in protein expression levels. N. meningitidis strain 8047 was subjected to serial passage in the presence of P1.2, a PorA-specific bactericidal monoclonal antibody. Rapid development of resistance to bactericidal activity was associated with a switch in the PorA repeat tract from 11G to 10G. Phase variants with a 10G repeat tract exhibited a 2-fold reduction in surface expression of PorA protein. A mutS mutant of strain 8047, with an elevated phase variation rate, exhibited a higher rate of escape and an association of escape with 10G and 9G variants, the latter having a 13-fold reduction in surface expression of PorA. We conclude that graduated reductions in the surface expression of outer membrane proteins mediated by phase variation enable meningococci to escape killing in vitro by bactericidal antibodies. These findings indicate how phase variation could have a major impact on immune escape and host persistence of meningococci.
authors: Department of Genetics, University of Leicester, Leicester, United Kingdom.
authors: Isfahan
authors: I
authors: Tauseef
authors: Youssif M
authors: YM
authors: Ali
authors: Christopher D
authors: CD
authors: Bayliss
mesh_terms: D000328:Adult; D000907:Antibodies, Bacterial / Q000276:immunology*; D000911:Antibodies, Monoclonal / Q000276:immunology; D000940:Antigenic Variation; D020869:Gene Expression Profiling; D006801:Humans; D057131:Immune Evasion; D050296:Microbial Viability; D009345:Neisseria meningitidis / Q000235:genetics* / Q000276:immunology* / Q000472:pathogenicity; D018272:Porins / Q000235:genetics* / Q000276:immunology*; D012692:Serial Passage
chemical_list: D000907:Antibodies, Bacterial; D000911:Antibodies, Monoclonal; D018272:Porins; C057699:porin protein, Neisseria
references: Infect Immun. 1999 May;67(5):2406-13
references: 10225902
references: Epidemiol Infect. 1987 Dec;99(3):591-601
references: 3123263
references: Nature. 2000 Feb 10;403(6770):665-8
references: 10688204
references: Clin Microbiol Rev. 2004 Jul;17(3):581-611, table of contents
references: 15258095
references: Infect Immun. 2012 Jan;80(1):187-94
references: 22064712
references: Infect Immun. 2007 Nov;75(11):5434-42
references: 17664268
references: Clin Vaccine Immunol. 2006 Apr;13(4):486-91
references: 16603616
references: FEMS Microbiol Rev. 2007 Jan;31(1):52-63
references: 17233635
references: J Bacteriol. 2010 Feb;192(3):691-701
references: 19948796
references: Microb Pathog. 2009 May;46(5):253-60
references: 19486642
references: Nat Rev Microbiol. 2009 Jul;7(7):493-503
references: 19503065
references: J Infect Dis. 2003 Mar 1;187(5):869-71
references: 12599063
references: Proc Natl Acad Sci U S A. 2010 Nov 9;107(45):19490-5
references: 20962280
references: J Infect Dis. 2008 Apr 1;197(7):1053-61
references: 18419542
references: Mol Microbiol. 2000 Jul;37(1):207-15
references: 10931317
references: Infect Immun. 2008 Nov;76(11):5038-48
references: 18694967
references: Microbiology (Reading). 2004 Sep;150(Pt 9):3001-3012
references: 15347758
references: Vaccine. 2003 Jun 20;21(21-22):2871-6
references: 12798629
references: Epidemiol Infect. 2005 Oct;133(5):883-9
references: 16181509
references: Infect Immun. 2004 Nov;72(11):6503-10
references: 15501781
references: Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):6103-7
references: 11983903
references: Expert Opin Biol Ther. 2011 Jul;11(7):969-85
references: 21615224
references: Microbiology (Reading). 2012 Apr;158(Pt 4):869-876
references: 22241045
references: Vaccine. 2009 Jun 24;27 Suppl 2:B64-70
references: 19464092
references: Annu Rev Genet. 2006;40:307-33
references: 17094739
references: J Clin Invest. 2001 Mar;107(6):657-62
references: 11254662
references: J Clin Microbiol. 2005 Feb;43(2):832-7
references: 15695688
references: Clin Diagn Lab Immunol. 1995 Jan;2(1):69-72
references: 7719916
references: J Med Microbiol. 2004 Jun;53(Pt 6):515-518
references: 15150331
references: FEMS Microbiol Rev. 2009 May;33(3):504-20
references: 19222587
references: J Clin Microbiol. 2011 Feb;49(2):506-12
references: 21123536
references: Infect Immun. 2000 Dec;68(12):6685-90
references: 11083782
references: Proc Natl Acad Sci U S A. 2006 Jul 18;103(29):10834-9
references: 16825336